Finance

Lists
OLY1:FRA
Olympus Corp
€9.97
-0.06%
(-0.0060) 1D
Nov 13, 10:00:00 PM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for OLY1...
Open
€9.97
High
€9.97
Low
€9.97
Mkt. cap
12.18B
Avg. vol.
158.00
Volume
0.00
52-wk high
€11.67
52-wk low
€7.01
No. of employees
28K
Open
€9.97
High
€9.97
Low
€9.97
Mkt. cap
12.18B
Avg. vol.
158.00
Volume
0.00
52-wk high
€11.67
52-wk low
€7.01
No. of employees
28K
News stories
From web sources and news partners
Profile
Olympus Corporation is a Japanese manufacturer of optics and reprography products, headquartered in Hachioji, Tokyo. Olympus was founded on October 12, 1919 as Takachiho Seisakusho by Takeshi Yamashita, initially specializing in microscopes and thermometers, and later in imaging. In 1921, the name Olympus was registered as a trademark. In 1942, the company was renamed Takachiho Optical Industries, and in 1949 it was renamed Olympus Optical Co., Ltd. In 2003, the company adopted its current name, Olympus Corporation. Olympus holds roughly a 70 percent share of the global endoscope market, estimated to be worth approximately US$2.5 billion. As of 2025, endoscopes and related surgical technologies are now Olympus's exclusive product line. It was formerly also a maker of cameras, camera lenses and dictaphones, until it divested this part to OM Digital Solutions in 2020. It divested from its microscopy and scientific imaging division in 2023, selling it to Bain Capital for approximately $3.1 billion; the division operates as Evident Corporation. Wikipedia
About Olympus Corp
CEOYasuo Takeuchi
Employees28.1K
FoundedOct 12, 1919
Headquarters-
SectorHealth Care
IndustryMedical device
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
261.04B
295.28B
254.80B
269.19B
Cost of goods sold
96.15B
102.52B
80.82B
78.06B
Cost of revenue
96.15B
102.52B
80.82B
78.06B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
125.65B
104.14B
125.56B
126.10B
Operating expense
140.86B
133.39B
128.74B
135.24B
Total operating expenses
237.01B
235.91B
209.56B
213.30B
Operating income
24.04B
59.37B
45.24B
55.89B
Other non operating income
-
-866.00M
482.00M
-
EBT including unusual items
22.13B
27.08B
41.30B
55.04B
EBT excluding unusual items
22.13B
59.58B
43.56B
55.04B
Income tax expense
7.96B
2.26B
15.23B
22.00B
Effective tax rate
35.98%
8.36%
36.87%
39.97%
Other operating expenses
15.21B
-5.95B
3.18B
9.15B
Net income
14.17B
24.82B
26.07B
33.04B
Net profit margin
5.43%
8.40%
10.23%
12.28%
Earnings per share
-
-
-
-
Interest and investment income
356.00M
3.96B
958.50M
1.45B
Interest expense
-2.34B
-2.88B
-2.62B
-2.41B
Net interest expenses
-1.99B
1.09B
-1.66B
-966.00M
Depreciation and amortization charges
-
35.20B
-
-
EBITDA
41.76B
75.92B
62.97B
74.04B
Gain or loss from assets sale
-
12.08B
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps